|
Dr. Haffner is Professor of Internal Medicine at the University of Texas Health Science Center, Department of Medicine, Division of Clinical Epidemiology in San Antonio, Texas. Dr. Haffner is certified in Internal Medicine, Endocrinology, and Metabolism by the American Board of Internal Medicine and is a Fellow of the American College of Epidemiology. He currently belongs to many professional organizations including: American Heart Association, Fellow Council on Epidemiology; Endocrine Society; American College of Epidemiology; American Society for Clinical Investigation; American Academy of Physicians, as well as sits on the editorial board for the Journal of Clinical Endocrinology and Metabolism, Diabetes and Circulation. Dr. Haffner has published more than 350 scientific publications and has written many book chapters and review articles in his field. His main research interests lie in insulin resistance and type 2 diabetes as well as diabetes and cardiovascular disease. Dr. Haffner wrote the American Diabetes Association technical review on diabetic dyslipidemia, which suggested that type 2 diabetes might be considered a coronary heart disease equivalent. This hypothesis eventually was accepted by the National Cholesterol Education Program (NCEP ATPIII), of which Dr. Haffner was a consultant. Dr. Haffner has also helped establish that the pre-diabetic state is atherogenic.
| 